Revamped Akay Bioactives graces nutraceuticals scene touting botanical blend against dementia

18 Oct 2023 — With the launch of its new brand, Akay Bioactives, the Oterra Group debuts its renewed business outlook along with its CurQfen supplement that stunts the progression of Alzheimer’s dementia. The curcumin-fenugreek blend alters the biomarkers responsible for the advancement of the disease, particularly brain-derived neurotrophic factor (BDNF), which plays a role in cognition and neuronal survival.